Asterias Biotherapeutics Stock Working Capital
Asterias Biotherapeutics fundamentals help investors to digest information that contributes to Asterias Biotherapeutics' financial success or failures. It also enables traders to predict the movement of Asterias Stock. The fundamental analysis module provides a way to measure Asterias Biotherapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Asterias Biotherapeutics stock.
Asterias |
Asterias Biotherapeutics Company Working Capital Analysis
Asterias Biotherapeutics' Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Asterias Biotherapeutics Working Capital | 19.54 M |
Most of Asterias Biotherapeutics' fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Asterias Biotherapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionIn accordance with the company's disclosures, Asterias Biotherapeutics has a Working Capital of 19.54 M. This is 95.41% lower than that of the sector and 96.37% lower than that of the Working Capital industry. The working capital for all United States stocks is 98.68% higher than that of the company.
Asterias Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Asterias Biotherapeutics' direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Asterias Biotherapeutics could also be used in its relative valuation, which is a method of valuing Asterias Biotherapeutics by comparing valuation metrics of similar companies.Asterias Biotherapeutics is currently under evaluation in working capital category among its peers.
Asterias Fundamentals
| Return On Equity | -93.17 | |||
| Return On Asset | -0.68 | |||
| Profit Margin | (4.60) % | |||
| Current Valuation | 40.31 M | |||
| Shares Outstanding | 55.66 M | |||
| Shares Owned By Insiders | 40.33 % | |||
| Shares Owned By Institutions | 13.75 % | |||
| Number Of Shares Shorted | 409.74 K | |||
| Price To Earning | (3.41) X | |||
| Price To Book | 2.02 X | |||
| Price To Sales | 67.77 X | |||
| Revenue | 731 K | |||
| Gross Profit | 3.88 M | |||
| EBITDA | (41.26 M) | |||
| Net Income | (20.3 M) | |||
| Cash And Equivalents | 12.59 M | |||
| Cash Per Share | (0.61) X | |||
| Total Debt | 16 K | |||
| Debt To Equity | 0.16 % | |||
| Current Ratio | 6.50 X | |||
| Book Value Per Share | 1.16 X | |||
| Cash Flow From Operations | (15.82 M) | |||
| Short Ratio | 2.31 X | |||
| Earnings Per Share | (0.37) X | |||
| Number Of Employees | 31 | |||
| Beta | 3.73 | |||
| Market Capitalization | 52.6 M | |||
| Total Asset | 66.98 M | |||
| Retained Earnings | (59.85 M) | |||
| Working Capital | 19.54 M | |||
| Current Asset | 29.79 M | |||
| Current Liabilities | 10.25 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Asterias Stock
If you are still planning to invest in Asterias Biotherapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Asterias Biotherapeutics' history and understand the potential risks before investing.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |